The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model.
Schwabl P, Hambruch E, Budas GR, Supper P, Burnet M, Liles JT, Birkel M, Brusilovskaya K, Königshofer P, Peck-Radosavljevic M, Watkins WJ, Trauner M, Breckenridge DG, Kremoser C, Reiberger T.
Schwabl P, et al.
Biomedicines. 2021 Jan 9;9(1):60. doi: 10.3390/biomedicines9010060.
Biomedicines. 2021.
PMID: 33435509
Free PMC article.